drugset / Trial / NCT05827016

A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

NCT05827016

Phase 3 Active not recruiting 1230 enrolled Bristol-Myers Squibb
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effectiveness of iberdomide maintenance to lenalidomide maintenance therapy after autologous stem cell transplantation (ASCT) in participants with newly diagnosed multiple myeloma (NDMM).

Timeline

Start
2023-06-22
Primary completion
2029-03-15
Completion
2036-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Iberdomide Small molecule
Comparator Lenalidomide Other / unclassified

Indications